Home

Windlas Biotech Limited

WINDLAS.NSNSEHealthcare
₹942.00Today12.19% · +₹102.35
Day rangeTrading above day high
₹0.00₹0.00
Open
₹0.00
Prev close
₹839.65
AskWarren SignalsUpdated 22:27 IST
Momentum Bullish(+12.19% today)Volume 5908% Above Avg52W Position Mid-range
Volume
23.4L
5908% above avg
Avg vol (20D)
39.0K
20-day baseline
Mkt cap
₹1,946.2Cr
Small Cap
P/E TTM
30.3×

Trade Windlas Biotech Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. The company sells generic medicines, health supplements, and custom-branded formulations under Windlas brand names. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

Classification

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Stock ExchangeNSE

Identifiers

Ticker SymbolWINDLAS.NS

Company Info

HeadquartersNot available
Employees1,385
Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.